Friday, May 29, 2020 6:59:00 PM
Institutional ownership here has buys kinda DOW-tied. This stock dropping BELOW that 200DMA would likely have a SERIOUS DOW TEST lower!
I know, I accidentally had an order in @ $167.00 when it dropped on the 27th. I went to put an ORDER just at or slightly above the 200DMA that day & realized I had a 300 share limit order in there from the 21st that was executing.
If the stock had the KIND OF WEAKNESS you're suggesting it would have TESTED that 200DMA right then & there! And TECHNICALLY it kinda should have...
The DOW performance on this MOSTLY institutionally-owned STOCK is KEY here imv,... If the DOW stays sideways or moves higher I don't see LH taking a dive UNLESS some directly negative news event happens.
Everything is tailwind right now with CORONAVIRUS ramp-up, with country getting back to normal, with economy re-opening, travel coming back, the advances in telemed, the NEW Medable deal, etc., etc., etc..
https://finance.yahoo.com/news/labcorp-partners-medable-expand-technology-132901628.html
By next Q, there's talk LH may even GET AHEAD of U.S. corporate & announce a dividend. It'd SHOCK the market & shoot LH into the $220 range for sure imho. But even without that they should be doing well enough to see $200 test into Q3 before long. I think there's a BETTER SHOT @ a $200 test than that $120 or whatever you were hoping to buy here... I just don't see it falling that far without some SERIOUS issue or market-wide event/pressure.
Recent LH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 03:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 02:59:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 02:55:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2024 02:11:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 09:15:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 08:36:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2024 04:06:07 PM
- Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients • PR Newswire (US) • 11/26/2024 01:05:00 PM
- Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients • PR Newswire (US) • 11/26/2024 12:52:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/25/2024 01:14:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/22/2024 09:56:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2024 08:20:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 12:13:51 PM
- Labcorp CFO Glenn Eisenberg Announces Plans to Retire • PR Newswire (US) • 11/19/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 01:16:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 01:44:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 01:18:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 01:15:34 PM
- Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience • Business Wire • 11/04/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2024 03:35:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2024 01:26:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/24/2024 08:21:46 PM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM
North Bay Resources Commences Fran Gold Winter Ore Shipment to Bishop Gold Mill, California • NBRI • Dec 2, 2024 9:07 AM
VAYK Reached Agreement on Terms to Acquire $1 Million Company for Disruptive Airbnb Strategy • VAYK • Dec 2, 2024 9:00 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM